| |
 |

 
University
Email Address: trosenberger@medicine.nodak.edu
Office Phone:
701-777-0591
Lab Phone:
701-777-0590
Office Fax: 701-777-4490
|
GRADUATE
STUDENT POSITIONS ARE NOW CURRENTLY AVAILABLE
Keywords:
Alzheimers disease, multiple sclerosis, cerebral ischemia,
spinal cord injury, AIDS-related dementia, neurodegeneration,
neuroinflammation, brain, lipid metabolism, lipid-mediated
signal transduction, fatty acid metabolism, phospholipid
metabolism, arachidonic acid, eicosanoids, ether phospholipid,
plasmalogens, phospholipases A2, phospholipases
C, analytical lipid techniques
Education/Training:
- Postdoctoral Fellow, National Institutes on Aging, National
Institutes of Health, Bethesda, Maryland
- Ph.D., Medical Biochemistry, The Ohio State University,
Columbus, Ohio
Research Interest:
Inflammation induced tissue injury is a major and primary
contributing factor to the pathogenesis of a variety of
human brain diseases including; cerebral ischemia, spinal
cord injury, multiple sclerosis, AIDS-related dementia,
and Alzheimers disease. Inflammation induces the production,
by activated microglia and astrocytes, of the pro-inflammatory
cytokines (e.g. IL-1, TNFa, etc.). These cytokines bind
to receptors that, among other things, couple to “effector”
enzymes such as phospholipases A2 and phospholipases
C, provoking pathological lipid-mediated signaling cascades.
Induction of these cascades is known to disrupt membrane
phospholipid metabolism, increase the expression of enzymes
found in the inflammatory cascades, and ultimately result
in altered cellular homeostasis and cell death. Unfortunately,
little is known concerning the relative contribution that
specific inflammation-induced signaling pathways play
in the progression of neurodegenerative events associated
with these diseases.
Our long-term goal is to understand the extent
by which alterations in lipid-mediated signal transduction
contribute to the progression of injury associated with
neuroinflammation and to use this knowledge to develop
therapeutic strategies to treat these diseases. Studies
in our laboratory include: identifying lipid-mediated
signaling pathways that contribute to the progression
of inflammatory events in the central nervous system,
identifying the specific roles phospholipases A2
and C play in the progression of disease, and to distinguish
the role that ether phospholipid metabolism has in normal
and injured brain.
Refereed Publications:
- Rosenberger,
T.A.,
Farooqui, A.A., and Horrocks, L.A. (2007) Bovine Brain
Diacylglycerol Lipase: Substrate Specificity and Activation
by Cyclic AMP-dependent Protein Kinase Lipids
42, 187-95.
- Golovko,
M.Y., Rosenberger, T.A., Fedderson, S.,
Færgeman, N.J., and Murphy, E.J. (2007) a-Synuclein
gene-ablation increases docosahexaenoic acid incorporation
and turnover in brain phospholipids J. Neurochem.
101, 201-211.
- Ma, K, Deutsch, J, Villacreses,
N.E., Rosenberger, T.A., Rapoport, S.I.,
and Shetty, U. (2006) Measuring brain uptake and incorporation
into brain phosphatidylinositol of plasma myo-[2H6]inositol
in unanesthetized rats: An approach to estimate in vivo
brain phosphatidylinositol turnover. Neurochem. Res.
31, 759-765.
- Golovko,
M.Y., Rosenberger, T.A., Faergeman, N.J.,
Seddersen, S., Cole, N.B., Pribill, I., Berger, J., Nussbaum,
R.L., and Murphy, E.J. (2006) Acyl-CoA synthetase activity
links wild-type but not mutant a-synuclein
to brain arachidonate metabolism. Biochemistry.
45, 6956-6966.
- Bazinet
RP, Weis MT, Rapoport SI, Rosenberger TA.
(2006) Valproic acid selectively inhibits conversion of
arachidonic acid to arachidonoyl-CoA by brain microsomal
long-chain fatty acyl-CoA synthetases: relevance to bipolar
disorder. Psychopharmacology 184(1):122-9.
- Bazinet,
R.P., Lee, H., Felder, C.C., Porter, A.C., Rapoport, S.I.,
and Rosenberger, T.A. (2005) Rapid high-energy
microwave fixation is required to determine the anandamide
(N-arachidonoylethanolamine) concentration of rat brain.
Neurochem. Res. 30: 597-601.
- Patrick,
C.B., McHowat, J., Rosenberger, T.A.,
Rapoport, S.I., and Murphy, E.J. (2005) Arachidonic acid
incorporation and turnover is decreased in sympathetically
denervated rat heart. Amer. J. Physiol. Heart Circ.
Physiol. 288: H2611-H2619.
- Lee,
H., Villacreses, N.E., Rapoport, S.I., and Rosenberger,
T.A. (2004) In vivo imaging detects
a transient increase in brain arachidonic acid metabolism:
A potential marker of neuroinflammation. J. Neurochem.
91: 936-945.
- Rosenberger,
T.A.,
Villacreses, N.E., Hovda, J.T., Bosetti, F., Weerasinghe,
G., Wine, R.N., Harry, G.J., and Rapoport, S.I. (2004)
Rat brain arachidonic acid metabolism is increased by
a 6-day intracerebral ventricular infusion of bacterial
lipopolysaccharide. J. Neurochem. 88:
1168-1178.
- Bosetti,
F., Weerasinghe, G., Rosenberger, T.A.,
and Rapoport, S.I. (2003) Valproic acid down-regulates
the conversion of arachidonic acid to eicosanoids via
cyclooxygenase-1 and -2 in rat brain. J. Neurochem.
85: 690-696.
- Rosenberger,
T.A.,
Villacreses, N.E., Contreras, M.A., Bonventre, J.V., and
Rapoport, S.I. (2003) Altered brain lipid metabolism in
the cytosolic phospholipase A2 (cPLA2)
knockout mouse. J. Lipid Res. 44: 109-117.
- Deutsch, J., Rapoport, S.I., and Rosenberger,
T.A. (2003) Valproyl-CoA and esterified valproate
are not found in brains of rats treated with valproic
acid, but the brain concentrations of CoA and acetyl-CoA
are altered. Neurochem. Res. 28: 861-866.
- Rosenberger,
T.A.,
Hovda, J.T., and Peters, J.M. (2002) Targeted disruption
of the nuclear hormone receptor, PPARb (d), results in
distinct gender differences in mouse brain phospholipid
and esterified FA levels. Lipids 37:
495-500.
-
Purdon, A.D., Rosenberger, T.A., Shetty,
H.U., and Rapoport, S.I., (2002) Energy consumption by
phospholipid metabolism in mammalian brain. Neurochem.
Res. 27: 1641-1647.
- Rosenberger,
T.A.,
Oki, J., Purdon, A.D., Rapoport, S.I., and Murphy, E.J.
(2002) Rapid synthesis and turnover of brain microsomal
ether phospholipids in the adult rat. J. Lipid Res.
43: 59-68.
-
Bosetti, F., Rintala, J., Seemann, R., Rosenberger,
T.A., Contreras, M.A., Rapoport, S.I., and Chang,
M.C.J. (2002) Chronic lithium downregulates cyclooxygenase-2
activity and prostaglandin E2 concentration
in rat brain. Mol. Psychiatry. 7: 845-850.
- Deutsch,
J., Rapoport, S.I., and Rosenberger, T.A.
(2002) Coenzyme A and short-chain acyl-CoA species in
control and ischemic rat brain. Neurochem. Res.
27: 1577-1582.
-
Contreras, M.A., Chang, M.C.J., Rosenberger, T.A.,
Sheaff-Greiner, R., Myers, C.S., Salem, N., and Rapoport,
S.I. (2001) Chronic nutritional deprivation of n-3 a-linolenic
acid does not affect n-6 arachidonic acid recycling within
brain phospholipids of awake rats J. Neurochem.
79: 1090-1099.
-
Chang, M.C.J., Contreras, M.A., Rosenberger, T.A.,
Rintala, J., Bell, J.M., and Rapoport, S.I. (2001) Chronic
valproate treatment decreases the in vivo turnover
of arachidonic acid in brain phospholipids: A possible
common effect of mood stabilizers. J. Neurochem.
77: 796-803.
- Murphy,
E.J., Rosenberger, T.A., Patrick, C.B.,
and Rapoport, S.I. (2000) Arachidonic acid targets phospholipids
and palmitate targets neutral lipids in hearts of awake
rats. Lipids 35: 891-898.
-
Rintala, J., Seemann, R., Chandrasekaran, K., Rosenberger,
T.A., Chang, L., Contreras, M., Rapoport, S.I.,
and Chang, M.C.J. (1999) A 85 kDa cytosolic phospholipase
A2 is a target for chronic lithium in rat brain.
NeuroReport 10: 3887-3890.
-
Farooqui, A.A., Yang, H.C., Rosenberger, T.A.,
and Horrocks, L.A. (1997) Phospholipase A2
and its role in brain tissue. J. Neurochem. 69:
889-901.
- Murphy,
E.J., Rosenberger, T.A., and Horrocks,
L.A. (1997) Effects of maturation on the phospholipid
and phospholipid fatty acid compositions in primary rat
cortical astrocytes cell cultures. Neurochem. Res.
22: 1205-1213.
- Murphy, E.J., Rosenberger, T.A., and
Horrocks, L.A. (1996) Separation of neutral lipids by
high-performance liquid chromatography: quantification
by ultraviolet, light scattering and fluorescence detection.
J. Chromatogr. B Biomed. Appl. 685: 9-14.
-
Murphy, E.J., Haun, S.E., Rosenberger, T.A.,
and Horrocks, L.A. (1995) Altered lipid metabolism in
the presence and absence of extracellular Ca2+
during combined oxygen-glucose deprivation in primary
astrocyte cultures. J. Neurosci. Res. 42:
109-116.
- Murphy,
E.J., Slivka, A.P., Rosenberger, T.A.,
and Horrocks, L.A. (1993) High-performance liquid chromatography
separation and quantitation of methylprednisolone from
rat brain. Anal. Biochem. 209: 339-342.
Non-refereed Publications:
- Deutsch, J., and Rosenberger, T.A.
(2005) HPLC analysis of acyl-coenzyme A esters from mammalian
tissue, in HPLC of Acyl Lipids (Lin, J. and McKeon,
T.A. editors) HNB Publishing, New York 499-520.
- Farooqui, A.A., Rosenberger, T.A.,
and Horrocks, L.A. (1997) Arachidonic acid, neurotrauma
and neurodegenerative diseases, in Fatty Acids: Biochemistry
and Behavior, (Mostofsky, D.I. and Yehuda, S. editors)
Humana Press, Totowa, 277-295.
|
|